Search Results 2081-2090 of 18902 for Relapse
Likely to have near normal lifespan if not for the presence of relapsed/refractory lymphoma. The Patients with evidence of HBV are eligible provided there ...
... relapsed or progressed from initial or systemic disease. . Participation eligibility. Participant eligibility includes age, gender, type and stage of disease ...
The purpose of this study is to assess the safety and tolerability of escalating intratumoral doses of mRNA-2752 in participants with relapsed/refractory solid ...
... relapse are eligible - Prior organ transplantation. Note: Other protocol defined Inclusion/Exclusion Criteria may apply. Eligibility last updated 12/29/23 ...
a) Subjects who relapsed, progressed, or were intolerant to standard therapy, have a disease for which no therapy with a known overall survival benefit ...
This is a Phase 1b/2 open-label study to evaluate the safety/efficacy of MEDI-551 + MEDI0680 (AMP-514) in participants with relapsed or refractory ...
... relapse. A Study to Build Translational Science through an Online Social Media Community Partnership Among Minnesota Communities, the CTSA Community ...
... relapsed or progressed following local standard therapies or for which no standard therapy is available. Platinum prior exposure unless it is ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!